Sofinnova Raises €472m To Build Europe’s Biggest Early-Stage Investment Fund

Reflects Booming Global Life Sciences VC Sector

 
• By Andrew McConaghie

The VC firm is making the most of a surge of capital from new and established investors who believe in the promise of European biopharma start-ups.

Euros in test tube
Investment in Europe's sector is growing fast, with global biopharma VC fundraising set to break records in 2021. • Source: Getty Images

More from Business

More from Scrip